Novel Small Molecule Immunomodulator AVR-48 as an Adjuvant for Influenza Vaccine
Saturday, April 26, 2025
8:15am – 8:30am HST
Location: Convention Center: 328
Adam Dayoub, AyuVis Research Inc., Fort Worth, TX, United States; Santosh Panda, Washington University in St. Louis School of Medicine, Olivette, MO, United States; William Barrett, TCU and UNTHSC School of Medicine, houston, TX, United States; Eesha Acharya, Ayuvis Research inc, Grapevine, TX, United States; Suchismita Acharya, AyuVis Research Inc., Grapevine, TX, United States; David Riley, Texas Christian University School of Medicine, Westlake, TX, United States
Presenting Author(s)
David M. Riley, MD (he/him/his)
Chief Medical Officer AyuVis Research Inc. Fort Worth, Texas, United States
Disclosure(s):
David M. Riley, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
